|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
2 |
1.000
|
|
|
|
adenylate cyclase inhibiting adrenergic receptor signaling pathway
|
GO:0071881 |
1 |
1.000
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
1 |
1.000
|
|
|
|
positive regulation of phosphatidylinositol biosynthetic process
|
GO:0010513 |
3 |
1.000
|
|
|
|
phospholipase c activating adrenergic receptor signaling pathway
|
GO:0071882 |
1 |
1.000
|
|
|
|
adenylate cyclase inhibiting opioid receptor signaling pathway
|
GO:0031635 |
1 |
1.000
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
1 |
1.000
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
10 |
1.000
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
1 |
1.000
|
|
|
|
activation of mapk activity by adrenergic receptor signaling pathway
|
GO:0071883 |
3 |
1.000
|
|
|
|
epidermal growth factor activated receptor transactivation by g protein coupled receptor signaling pathway
|
GO:0035625 |
4 |
1.000
|
|
|
|
negative regulation of wnt protein secretion
|
GO:0061358 |
1 |
1.000
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
11 |
1.000
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
22 |
0.999
|
|
|
|
opioid receptor signaling pathway
|
GO:0038003 |
4 |
0.999
|
|
|
|
positive regulation of glucocorticoid secretion
|
GO:2000851 |
4 |
0.999
|
|
|
|
regulation of large conductance calcium activated potassium channel activity
|
GO:1902606 |
2 |
0.998
|
|
|
|
desensitization of g protein coupled receptor protein signaling pathway by arrestin
|
GO:0002032 |
2 |
0.998
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
43 |
0.996
|
|
|
|
gastro intestinal system smooth muscle contraction
|
GO:0014831 |
2 |
0.995
|
|
|
|
adenylate cyclase activating dopamine receptor signaling pathway
|
GO:0007191 |
3 |
0.994
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
13 |
0.988
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
6 |
0.986
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.974
|
|
|
|
negative regulation of lipid catabolic process
|
GO:0050995 |
9 |
0.972
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
19 |
0.972
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
43 |
0.966
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
55 |
0.964
|
|
|
|
activation of phospholipase c activity
|
GO:0007202 |
7 |
0.959
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.957
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
29 |
0.952
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.950
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
35 |
0.950
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
14 |
0.940
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
37 |
0.938
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.936
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.934
|
|
|
|
dopamine receptor signaling pathway
|
GO:0007212 |
10 |
0.932
|
|
|
|
intestine smooth muscle contraction
|
GO:0014827 |
2 |
0.925
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.921
|
|
|
|
receptor transactivation
|
GO:0035624 |
4 |
0.920
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.914
|
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
1 |
0.910
|
|
|
|
positive regulation of phospholipid biosynthetic process
|
GO:0071073 |
4 |
0.906
|
|
|
|
phospholipase c activating dopamine receptor signaling pathway
|
GO:0060158 |
2 |
0.903
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.901
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
58 |
0.894
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
15 |
0.891
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.891
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.890
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.881
|
|
|
|
adenylate cyclase activating adrenergic receptor signaling pathway
|
GO:0071880 |
3 |
0.881
|
|
|
|
camp metabolic process
|
GO:0046058 |
61 |
0.877
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.876
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
38 |
0.868
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.865
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.860
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
14 |
0.860
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
48 |
0.852
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.849
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.839
|
|
|
|
positive regulation of release of sequestered calcium ion into cytosol
|
GO:0051281 |
16 |
0.836
|
|
|
|
positive regulation of cortisol secretion
|
GO:0051464 |
4 |
0.833
|
|
|
|
regulation of phosphatidylinositol biosynthetic process
|
GO:0010511 |
5 |
0.830
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.827
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.820
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.819
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.818
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.817
|
|
|
|
wnt protein secretion
|
GO:0061355 |
1 |
0.812
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.811
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
33 |
0.810
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
18 |
0.810
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.810
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.809
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.807
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
6 |
0.804
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.798
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.795
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
37 |
0.790
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
9 |
0.785
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.782
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
17 |
0.779
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.779
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.767
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
12 |
0.760
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
35 |
0.760
|
|
|
|
hippo signaling
|
GO:0035329 |
20 |
0.757
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.752
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.751
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
41 |
0.748
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.747
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.747
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.744
|
|
|
|
camp mediated signaling
|
GO:0019933 |
23 |
0.743
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.737
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.735
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.734
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.733
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.722
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
26 |
0.711
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
65 |
0.706
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.703
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.699
|
|
|
|
positive regulation of large conductance calcium activated potassium channel activity
|
GO:1902608 |
2 |
0.699
|
|
|
|
adaptation of signaling pathway
|
GO:0023058 |
7 |
0.699
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.697
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.692
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.692
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.687
|
|
|
|
positive regulation of adenylate cyclase activity
|
GO:0045762 |
12 |
0.685
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.678
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.678
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.675
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.675
|
|
|
|
behavioral defense response
|
GO:0002209 |
0 |
0.672
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.661
|
|
|
|
activation of protein kinase b activity
|
GO:0032148 |
14 |
0.660
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.659
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.657
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.656
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.650
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.646
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.640
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.639
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
18 |
0.638
|
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
41 |
0.631
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.631
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.629
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.626
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.622
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
51 |
0.621
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.619
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.615
|
|
|
|
positive regulation of cell matrix adhesion
|
GO:0001954 |
23 |
0.615
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.612
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.612
|
|
|
|
negative regulation of nucleotide biosynthetic process
|
GO:0030809 |
11 |
0.610
|
|
|
|
behavioral response to ethanol
|
GO:0048149 |
2 |
0.607
|
|
|
|
positive regulation of corticosteroid hormone secretion
|
GO:2000848 |
5 |
0.606
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
20 |
0.597
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.595
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.595
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
45 |
0.595
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.594
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.593
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.591
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.585
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.585
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.583
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
49 |
0.581
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.580
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.575
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
22 |
0.571
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.570
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.563
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.550
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.549
|
|
|
|
regulation of glucocorticoid secretion
|
GO:2000849 |
4 |
0.548
|
|
|
|
regulation of wnt protein secretion
|
GO:0061356 |
1 |
0.546
|
|
|
|
cortisol secretion
|
GO:0043400 |
4 |
0.544
|
|
|
|
regulation of tube size
|
GO:0035150 |
18 |
0.543
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.536
|
|
|
|
head development
|
GO:0060322 |
108 |
0.530
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.530
|
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.520
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.518
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.509
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.509
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
49 |
0.508
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.507
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.505
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.505
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.504
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.503
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.500
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.499
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.498
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.493
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.493
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.492
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.488
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.488
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.487
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.486
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
51 |
0.483
|
|
|
|
negative regulation of protein kinase b signaling
|
GO:0051898 |
17 |
0.481
|
|
|
|
negative regulation of camp biosynthetic process
|
GO:0030818 |
9 |
0.480
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.477
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.476
|
|
|
|
regulation of corticosteroid hormone secretion
|
GO:2000846 |
5 |
0.471
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
50 |
0.468
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.468
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.465
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
36 |
0.464
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.462
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
53 |
0.462
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.456
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
40 |
0.456
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.452
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.452
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.450
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.448
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.445
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
13 |
0.443
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.442
|
|
|
|
ruffle organization
|
GO:0031529 |
18 |
0.440
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.439
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.438
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
42 |
0.437
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.436
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.432
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
18 |
0.431
|
|
|
|
glucocorticoid secretion
|
GO:0035933 |
4 |
0.429
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.428
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.426
|
Mouse |
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.424
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.422
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.422
|
|
|
|
male gonad development
|
GO:0008584 |
23 |
0.421
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
38 |
0.421
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.416
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.416
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.416
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.411
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.407
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.407
|
|
|
|
activation of mapk activity
|
GO:0000187 |
45 |
0.406
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.405
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.400
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.399
|
|
|
|
positive regulation of blood vessel endothelial cell migration
|
GO:0043536 |
16 |
0.397
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.397
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.397
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.395
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.392
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.390
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
44 |
0.388
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.385
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.385
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.384
|
|
|
|
regulation of phospholipase activity
|
GO:0010517 |
26 |
0.379
|
|
|
|
positive regulation of epidermal growth factor activated receptor activity
|
GO:0045741 |
8 |
0.379
|
|
|
|
androgen metabolic process
|
GO:0008209 |
9 |
0.378
|
|
|
|
negative regulation of g protein coupled receptor protein signaling pathway
|
GO:0045744 |
18 |
0.376
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.375
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.373
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.372
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.366
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.364
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.363
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.363
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.363
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.360
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.358
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.357
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.355
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.354
|
|
|
|
behavioral fear response
|
GO:0001662 |
0 |
0.354
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
4 |
0.352
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
13 |
0.351
|
|
|
|
cellular response to alkaloid
|
GO:0071312 |
11 |
0.346
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.346
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.346
|
|
|
|
ovulation cycle process
|
GO:0022602 |
9 |
0.345
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.342
|
|
|
|
protein kinase c signaling
|
GO:0070528 |
17 |
0.339
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.337
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
13 |
0.334
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.333
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.331
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.330
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.325
|
|
|
|
vasoconstriction
|
GO:0042310 |
11 |
0.324
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.323
|
|
|
|
system process
|
GO:0003008 |
349 |
0.321
|
Rat |
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.319
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
17 |
0.318
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.316
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.316
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.315
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.315
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.314
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.313
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.310
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.309
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.308
|
|
|
|
estrogen metabolic process
|
GO:0008210 |
6 |
0.306
|
|
|
|
negative regulation of peptide hormone secretion
|
GO:0090278 |
10 |
0.305
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
44 |
0.305
|
|
|
|
negative regulation of cyclic nucleotide biosynthetic process
|
GO:0030803 |
10 |
0.304
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.303
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.299
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.298
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.295
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.289
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.289
|
|
|
|
negative regulation of purine nucleotide biosynthetic process
|
GO:1900372 |
11 |
0.289
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.287
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.278
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.278
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.276
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.274
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.273
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.270
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.269
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.268
|
Mouse |
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.264
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
28 |
0.261
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.259
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
15 |
0.259
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.257
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.257
|
|
|
|
negative regulation of nitric oxide biosynthetic process
|
GO:0045019 |
5 |
0.255
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.253
|
|
|
|
positive regulation of cyclase activity
|
GO:0031281 |
13 |
0.253
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.249
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.247
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.245
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
16 |
0.244
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.243
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.240
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.238
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
41 |
0.237
|
|
|
|
positive regulation of calcium ion transport into cytosol
|
GO:0010524 |
20 |
0.237
|
|
|
|
regulation of wound healing
|
GO:0061041 |
56 |
0.237
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.236
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
22 |
0.235
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
22 |
0.235
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
19 |
0.225
|
|
|
|
negative regulation of camp metabolic process
|
GO:0030815 |
9 |
0.223
|
|
|
|
negative regulation of nucleotide metabolic process
|
GO:0045980 |
29 |
0.222
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.222
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.219
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.216
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.215
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.214
|
Rat |
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
39 |
0.214
|
|
|
|
regulation of lyase activity
|
GO:0051339 |
23 |
0.213
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.213
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
7 |
0.212
|
|
|
|
positive regulation of cation channel activity
|
GO:2001259 |
16 |
0.211
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.210
|
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.208
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.206
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.206
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.206
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.202
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.197
|
|
|
|
positive regulation of epidermal growth factor receptor signaling pathway
|
GO:0045742 |
11 |
0.196
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.195
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.195
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.192
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
67 |
0.192
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.191
|
|
|
|
positive regulation of oxidoreductase activity
|
GO:0051353 |
26 |
0.190
|
|
|
|
negative regulation of protein binding
|
GO:0032091 |
35 |
0.190
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.189
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.189
|
|
|
|
regulation of appetite
|
GO:0032098 |
1 |
0.188
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.188
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
75 |
0.185
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.185
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
51 |
0.184
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.182
|
|
|
|
luteinization
|
GO:0001553 |
2 |
0.176
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.174
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.173
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.173
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.172
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.171
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
40 |
0.170
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.169
|
|
|
|
positive regulation of erbb signaling pathway
|
GO:1901186 |
11 |
0.168
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
5 |
0.168
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.168
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.166
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.165
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.165
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.165
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.165
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.163
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
41 |
0.163
|
|
|
|
steroid hormone secretion
|
GO:0035929 |
8 |
0.163
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.160
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.159
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.159
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.158
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
61 |
0.157
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.156
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.155
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.155
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.155
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.155
|
|
|
|
regulation of epidermal growth factor activated receptor activity
|
GO:0007176 |
14 |
0.155
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.152
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.151
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.150
|
|
|
|
regulation of release of sequestered calcium ion into cytosol
|
GO:0051279 |
27 |
0.150
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.149
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.149
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
29 |
0.145
|
|
|
|
regulation of cortisol secretion
|
GO:0051462 |
4 |
0.145
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.144
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.143
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
40 |
0.142
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.141
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.140
|
|
|
|
ovulation cycle
|
GO:0042698 |
9 |
0.138
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.138
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.137
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.137
|
|
|
|
negative regulation of peptide secretion
|
GO:0002792 |
11 |
0.136
|
|
|
|
desensitization of g protein coupled receptor protein signaling pathway
|
GO:0002029 |
7 |
0.136
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.135
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.134
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.133
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.132
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.131
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.131
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
3 |
0.128
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.127
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
61 |
0.127
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.127
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.124
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.123
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
63 |
0.123
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.123
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
37 |
0.123
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.123
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.122
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.121
|
|
|
|
negative regulation of hippo signaling
|
GO:0035331 |
6 |
0.121
|
|
|
|
cellular response to toxic substance
|
GO:0097237 |
4 |
0.120
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.120
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.120
|
|
|
|
response to alkaloid
|
GO:0043279 |
20 |
0.119
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.118
|
|
|
|
negative regulation of cyclic nucleotide metabolic process
|
GO:0030800 |
10 |
0.118
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.116
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.116
|
|
|
|
regulation of mitochondrial membrane potential
|
GO:0051881 |
23 |
0.114
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.113
|
Rat |
|
|
negative adaptation of signaling pathway
|
GO:0022401 |
7 |
0.112
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.112
|
|
|
|
cellular response to catecholamine stimulus
|
GO:0071870 |
7 |
0.112
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.112
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.112
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.111
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.111
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.111
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.111
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.109
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.109
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.109
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.109
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.108
|
|
|
|
palate development
|
GO:0060021 |
13 |
0.107
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.106
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.106
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.105
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.105
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.103
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.103
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.103
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.102
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.102
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.102
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.101
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.100
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.100
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
29 |
0.099
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.099
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.099
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.098
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
4 |
0.097
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
23 |
0.097
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.097
|
|
|
|
positive regulation of lyase activity
|
GO:0051349 |
16 |
0.096
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.096
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.095
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.093
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.091
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.091
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
47 |
0.091
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.091
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.091
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.090
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
28 |
0.089
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.089
|
|
|
|
adrenergic receptor signaling pathway
|
GO:0071875 |
9 |
0.089
|
|
|
|
cgmp biosynthetic process
|
GO:0006182 |
12 |
0.087
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.086
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
6 |
0.086
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
20 |
0.086
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.085
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.085
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.085
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.083
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.082
|
|